|
Market Closed -
OTC Markets
15:32:11 2026-08-11 EDT
|
5-day change | 1st Jan Change | ||
| 18.50 USD | +14.20% |
|
-.--% | - |
| 09-23 | European stocks slip as lack of progress on US-Iran peace lifts oil, yields | RE |
| 09-23 | Europe stocks rise as oil retreat aids sentiment; PMI data in focus | RE |
Company Valuation: Exosens
Data adjusted to current consolidation scope
| Fiscal Period: December | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| Market Cap 1 | 986.7 | 2,459 | 3,009 | - | - |
| Change | - | 149.26% | 22.34% | - | - |
| Enterprise Value (EV) 1 | 1,131 | 2,657 | 3,165 | 3,101 | 3,022 |
| Change | - | 134.98% | 19.1% | -2.02% | -2.55% |
| P/E | 31.9x | 57.7x | 38.1x | 26.2x | 21.9x |
| PBR | 2.39x | 5.51x | 5.88x | 5.02x | 4.28x |
| PEG | 0x | 1.5x | 0.5x | 0.6x | 1.1x |
| Capitalization / Revenue | 2.5x | 5.25x | 5.38x | 4.75x | 4.21x |
| EV / Revenue | 2.87x | 5.68x | 5.65x | 4.89x | 4.22x |
| EV / EBITDA | 9.54x | 17.5x | 17.4x | 14.8x | 12.3x |
| EV / EBIT | 11.9x | 20.8x | 21x | 17.4x | 14.8x |
| EV / FCF | 20.4x | 46.4x | 51.4x | 37.8x | 28.4x |
| FCF Yield | 4.9% | 2.16% | 1.94% | 2.65% | 3.52% |
| Dividend per Share 2 | 0.1 | 0.3 | 0.3797 | 0.519 | 0.6306 |
| Rate of return | 0.51% | 0.62% | 0.64% | 0.88% | 1.07% |
| EPS 2 | 0.61 | 0.84 | 1.55 | 2.254 | 2.694 |
| Distribution rate | 16.4% | 35.7% | 24.5% | 23% | 23.4% |
| Net sales 1 | 394.1 | 468.2 | 559.6 | 633.8 | 715.4 |
| EBITDA 1 | 118.5 | 151.6 | 181.5 | 209.4 | 245.3 |
| EBIT 1 | 95.3 | 127.6 | 150.7 | 178 | 204.7 |
| Net income 1 | 30.7 | 42.7 | 80.03 | 113.6 | 134.9 |
| Net Debt 1 | 144.1 | 197.7 | 155.7 | 91.73 | 12.71 |
| Reference price 2 | 19.43 | 48.45 | 59.10 | 59.10 | 59.10 |
| Nbr of stocks (in thousands) | 50,783 | 50,762 | 50,911 | - | - |
| Announcement Date | 3/3/25 | 2/23/26 | - | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 36.04x | 6.61x | 27.72x | 0.58% | 324B | |
| 30.78x | 2.88x | 17.1x | 1.54% | 250B | |
| 25.64x | 1.7x | 12.68x | 1.79% | 171B | |
| 34.48x | 5.02x | 21.07x | 0.99% | 161B | |
| 33.5x | 3.67x | 16.66x | 1.23% | 157B | |
| -685.49x | 1.73x | 39.15x | -.--% | 147B | |
| 16.71x | 1.63x | 11.69x | 2.75% | 118B | |
| 41.07x | 9.26x | 28.73x | 0.23% | 90.2B | |
| 19.53x | 1.66x | 13.56x | 1.9% | 89.64B | |
| Average | -49.75x | 3.80x | 20.93x | 1.22% | 167.6B | |
| Weighted average by Cap. | -38.97x | 3.96x | 21.47x | 1.16% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- EXENS Stock
- EXSNY Stock
- Valuation Exosens
Select your edition
All financial news and data tailored to specific country editions
